11 – 20 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing
- Contribution to journal › Article
- 2022
-
Mark
Immunomodulation therapy offers new molecular strategies to treat UTI
- Contribution to journal › Scientific review
- 2021
-
Mark
Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
- Contribution to journal › Debate/Note/Editorial
-
Mark
Active bacterial modification of the host environment through RNA polymerase II inhibition
- Contribution to journal › Article
-
Mark
A scientific journey from discovery to validation of efficacy in cancer patients : HAMLET and alpha1-oleate
- Contribution to journal › Article
-
Mark
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer
- Contribution to journal › Article
-
Mark
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex
- Contribution to journal › Article
-
Mark
Immunomodulation—A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
- Contribution to journal › Article
-
Mark
Molecular determinants of disease severity in urinary tract infection
- Contribution to journal › Scientific review
- 2020
-
Mark
Bladder cancer therapy without toxicity—A dose-escalation study of alpha1-oleate
- Contribution to journal › Article
